Groundbreaking research from SEGi University has brought new insights to light on Gorlin-Goltz Syndrome (GGS), a rare hereditary cancer disorder, through a compelling new case report and literature review. The study, published in the Journal of Pharmaceutical Research, offers clinicians and researchers a deeper understanding of diagnostic markers and the complexity of this syndrome, which...Read More